Skip to main content
Monica Kraft, MD, Pulmonology, New York, NY, The Mount Sinai Hospital

MonicaKraftMDMD, FACP, ATSF(She/Her)

Pulmonology New York, NY

Asthma & COPD, Critical Care Medicine

System Chair of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System

Dr. Kraft is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kraft's full profile

Already have an account?

  • Office

    1 Gustav Levy Place, Box 1118,
    5-02 Annenberg
    New York, NY 10029
    Phone+1 212-241-4200
    Fax+1 212-534-3488
  • Is this information wrong?

Summary

  • Dr. Monica Kraft is an internationally recognized physician-scientist renowned for her expertise in clinical and translational research concerning airway disease. Dr. Kraft joined the Icahn School of Medicine at Mount Sinai in July 2022 as System Chair of the Department of Medicine. She previously held a position as Chair at the University of Arizona College of Medicine-Tucson, where she also held a Professorship and was the Robert and Irene Flinn Endowed Chair in Medicine. Prior to her tenure at the University of Arizona, she served as the Charles Johnson Distinguished Professor of Medicine at Duke University Medical Center and as Chief of the Division of Pulmonary, Allergy and Critical Care Medicine. Dr. Kraft earned her MD degree from the University of California, San Francisco, and completed her residency at Harbor-UCLA Medical Center. Following this, she pursued a fellowship in Pulmonary and Critical Care Medicine at the University of Colorado Health Sciences Center. Throughout her career, she has been deeply involved in patient care, teaching, and extensive research, particularly in adult asthma and COPD. Her research interests include innate immune dysfunction, inflammation, infection in asthma, and personalized approaches to therapy. Dr. Kraft has an impressive publication record in esteemed journals and has received over 25 years of continuous funding from institutions such as the National Institutes of Health and the American Lung Association. She also had a notable H index of 83. She has been recognized with several awards, including the Presidential Early Career Award for Scientists and Engineers, a Distiguished Career award from the American Thoracic Society and election to American Association of Physicians. Additionally, she co-founded RaeSedo, Inc., where she serves as Chief Medical Officer, which focuses on therapies for inflammatory lung diseases.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
  • Harbor-UCA Medical Center
    Harbor-UCA Medical CenterMD, Internal Medicine, 1990 - 1991
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1987 - 1990
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1987

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2015 - 2026
  • NY State Medical License
    NY State Medical License 2022 - 2025
  • CA State Medical License
    CA State Medical License 1988 - 2025
  • CO State Medical License
    CO State Medical License 1991 - 2025
  • NC State Medical License
    NC State Medical License 2004 - 2024
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Elected Member American Association of Physicians, 2024
  • Elected Member American Clinical and Climatological Association, 2022
  • Distinguished Educator American College of Chest Physicians, 2020-2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
    Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International ConferenceMay 23rd, 2024

Grant Support

  • Mount Sinai StARR Program Resident ResearchNIH/NHLBI2024–2029
  • Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping CenterNIH/NIA2021–2026
  • Development of SP-A-Derived Peptidomimetics for the Treatment of Asthma - Phase IINIH2022–2024
  • The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)NIAID2020–2024
  • CC16: A Link Between Infection and Obstructive Airway DiseaseR01 NIH2019–2024
  • The University of Arizona-Banner Health Precision Medicine Initiative (PMI) or “All of Us” Research ProgramNIH/Office of the Director2022–2023
  • Surfactant protein A as Novel Therapeutic for AsthmaNIH NIAID R212018–2023
  • PrecISE Severe Asthma Clinical Trial NetworkNHLBI2017–2023
  • Development of Surfactant Protein A Peptidomimetics for the Treatment of AsthmaR41 NIH STTR2020–2022
  • Interdisciplinary Training in Cardiovascular ResearchNIH NHLBI2017–2022
  • CC16 in childhood and Resilience to persistent asthma in adult lifeR01 NIAID2017–2022
  • The University of Arizona-Banner Health Precision Medicine Initiative (PMI) or “All of Us” Research ProgramNIH/ Office of the Director2016–2022
  • Surfactant Protein A Regulation of Eosinophil Apoptosis in AsthmaNHLBI2014–2016
  • Duke Clinical Translational Science AwardNIH-NCATS2013–2014

Hospital Affiliations